21,406
Supporters

Generic drugs make up 80% of all prescriptions filled in the United States. But generic drug manufacturers cannot independently update their labels to warn of new side-effects and cannot be held accountable if their drugs injure or kill Americans.

Both brand name and generic manufacturers should be accountable for the safety of their products.  If no one is accountable, no one is safe.

Tell the FDA to act now to restore accountability because safety is an issue that cannot wait.

Letter to
Commissioner, U.S. Food and Drug Administration Margaret A. Hamburg, M.D.
Director, Office of Management and Budget Sylvia Mathews Burwell
We applaud you and your colleagues for taking the next steps towards revising regulations to allow generic drug manufactures to update their warning labels. We want to thank you for your efforts to restore the rights of Americans injured by generic drugs.

We believe it is critically important that all prescription medicines, including generic drugs, carry current and accurate safety warnings.

People who are hurt by generic drugs should have the same legal rights as those who are injured by brand name versions of the same medications. Both brand name and generic manufacturers should be accountable for the safety of their products. If no one is accountable, no one is safe.

We hope this issue will be addressed as quickly as possible in order to ensure generic drugs are safe and patients’ rights are restored. Safety is an issue that cannot wait.